Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ProSomnus Sleep Technologies, Inc.

ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAPQ
ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAP OSAPQ
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAP OSAPQ
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAP
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAP
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSAP
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Announces Third Quarter 2023 Investor Call and Business Update
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
71% of Self-identified Snorers Have Never Consulted a Healthcare Professional
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Reports First Quarter 2023 Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference Demonstrates Efficacy of ProSomnus Precision Oral Appliances
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Tickers OSA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.